First-Line Medications for Anger and Impulse Control in TBI
Beta-blockers (propranolol or pindolol) should be considered as first-line pharmacological treatment for anger and impulse control problems in adults with traumatic brain injury, with amantadine as an alternative option.
Recommended Approach
Primary Recommendation: Beta-Blockers
Propranolol is the most evidence-supported medication for managing aggression and anger after TBI 1, 2. The French recommendations for good practice specifically give propranolol a B grade recommendation for improving aggression 2. While beta-blockers were initially studied for mortality reduction in acute TBI 3, their mechanism of blunting the hyperadrenergic state makes them particularly suited for managing behavioral dyscontrol.
- Propranolol can reduce the intensity of agitation, though evidence on frequency reduction is mixed 4
- Pindolol is also mentioned as an option for scheduled treatment 1
- These work by antagonizing the excessive sympathetic activation that contributes to behavioral dysregulation post-TBI
Alternative First-Line Option: Amantadine
Amantadine has the strongest evidence base among all medications studied, with multiple RCTs showing benefit 5, 4. It is appropriate to recommend for treating both irritability and aggression in adults following TBI 5. The 2024 Canadian guideline update includes amantadine in behavioral management recommendations 6.
Second-Line Considerations
Mood Stabilizers
Carbamazepine and valproate are recommended as first-line treatment based on expert consensus, showing effectiveness on agitation and aggression 2. However, newer evidence on valproic acid has been inconsistent 4, and one small study showed no superiority over control 4.
Methylphenidate
Shows some positive findings for reducing anger 5, though individual response varies significantly 5.
What to Avoid
Benzodiazepines and Haloperidol
Explicitly avoid benzodiazepines and haloperidol for treating agitation and aggression in TBI 1. These can worsen cognitive function and paradoxically increase agitation.
Typical Antipsychotics
No evidence of efficacy for neuroleptics in general 2. Loxapine may be used only for acute crisis situations, not long-term management 2.
Atypical Antipsychotics
While olanzapine can be considered as a practical alternative for as-needed management 1, recent evidence shows it failed to demonstrate efficacy compared to controls 4. Use only when beta-blockers or amantadine are contraindicated or ineffective.
Clinical Algorithm
- Start with propranolol (or pindolol) as scheduled treatment for persistent anger/aggression
- Consider amantadine if beta-blockers are contraindicated (e.g., bradycardia, hypotension, asthma) or as an alternative first choice
- Add carbamazepine or valproate if monotherapy insufficient, though evidence is weaker
- Reserve olanzapine for breakthrough agitation only, not scheduled use
- Never use benzodiazepines or haloperidol
Important Caveats
Monitor cardiovascular effects carefully with beta-blockers, as they can cause hypotension and bradycardia, which are associated with poor outcomes in TBI 3. This is particularly important in the acute phase.
Individual response varies significantly - the evidence shows differential drug responses across individuals, particularly with methylphenidate and propranolol 5. If one agent fails, trying another class is reasonable.
Evidence quality remains limited - most recommendations are based on Level B or C evidence 6, with no Level A evidence available. The 2026 systematic review concludes there remain insufficient data to strongly recommend any single medication 4, though the pattern of evidence favors beta-blockers and amantadine most consistently.
Dexmedetomidine shows promise in acute settings for reducing agitation 4, 7, but is not practical for outpatient anger management.